SynthesisBMC neurology2026
Risk factors for HIV-associated neurocognitive impairment and frailty in aging people with HIV in Latin America: a systematic review.
Synthesis in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAs people living with HIV (PWH) in Latin America and the Caribbean (LAC) have longer life expectancy due to improved access to antiretroviral therapy (ART), complications such as HIV-associated neurocognitive impairment (NCI; including HIV-associated neurocognitive disorder [HAND]) and frailty are increasingly more prevalent. We aimed to identify the risk factors for neurocognitive impairment and frailty among aging PWH in LAC.
methodsWe conducted a systematic review following PRISMA guidelines. We searched five databases that reported on NCI, HAND or frailty in PWH in LAC. Eligible studies included observational studies, clinical trials or case series. Data were extracted on study characteristics, diagnostic tools utilized, prevalence estimates (when available) and associated risk factors of each condition of interest.
resultsA total of 83 studies met inclusion criteria: 71 focused on NCI (including HAND) and 14 on frailty (2 on both NCI and frailty). NCI and HAND prevalence ranged from 11% to 89%, with most studies using brief cognitive screening tools (NCI) rather than formal neuropsychological testing (HAND). Risk factors for both NCI included older age, lower education, female sex, low CD4 counts and psychosocial factors. ART use did not consistently protect against NCI. Only a small subset of studies employed complete neuropsychological test batteries, imaging or biomarker analysis. Frailty studies, primarily from Brazil, reported prevalence ranging from 8% to 50%. Frailty risk factors included older age, female sex, depression, low CD4 counts, malnutrition, and unemployment. Some studies reported no or inconsistent associations with traditional HIV characteristics.
conclusionsNCI and frailty are common and underrecognized conditions affecting aging PWH in LAC. Region-specific diagnostic approaches and targeted interventions are urgently needed to improve cognitive and functional health outcomes in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.